Laboratorio Reig Jofre S.A (RJF) - Total Assets

Latest as of September 2025: €355.15 Million EUR ≈ $415.21 Million USD

Based on the latest financial reports, Laboratorio Reig Jofre S.A (RJF) holds total assets worth €355.15 Million EUR (≈ $415.21 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Laboratorio Reig Jofre S.A - Total Assets Trend (2004–2024)

This chart illustrates how Laboratorio Reig Jofre S.A's total assets have evolved over time, based on quarterly financial data. Also see Laboratorio Reig Jofre S.A market cap and net worth for the company's overall valuation and market capitalisation.

Laboratorio Reig Jofre S.A - Asset Composition Analysis

Current Asset Composition (December 2024)

Laboratorio Reig Jofre S.A's total assets of €355.15 Million consist of 43.4% current assets and 56.6% non-current assets. Review RJF liabilities breakdown to assess the company's total debt and financial obligations.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 3.0%
Accounts Receivable €62.18 Million 18.0%
Inventory €63.77 Million 18.5%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €55.28 Million 16.0%
Goodwill €26.81 Million 7.8%

Asset Composition Trend (2004–2024)

This chart illustrates how Laboratorio Reig Jofre S.A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Laboratorio Reig Jofre S.A stock price today for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Laboratorio Reig Jofre S.A's current assets represent 43.4% of total assets in 2024, a decrease from 49.3% in 2004.
  • Cash Position: Cash and equivalents constituted 3.0% of total assets in 2024, down from 6.1% in 2004.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 12.0% in 2004.
  • Asset Diversification: The largest asset category is inventory at 18.5% of total assets.

Laboratorio Reig Jofre S.A Competitors by Total Assets

Key competitors of Laboratorio Reig Jofre S.A based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Sweden Skr81.26 Billion
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
China CN¥68.33 Billion
Sandoz Group AG
SW:SDZ
Switzerland CHF22.86 Billion
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
China CN¥17.01 Billion
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
China CN¥4.69 Billion
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
China CN¥2.53 Billion
Chongqing Taiji Industry Group Co Ltd
SHG:600129
China CN¥14.83 Billion
Bide Pharmatech Co. Ltd. A
SHG:688073
China CN¥2.54 Billion

Laboratorio Reig Jofre S.A - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.85 1.83 1.33
Quick Ratio 0.99 1.00 0.79
Cash Ratio 0.00 0.00 0.00
Working Capital €70.75 Million €67.02 Million €25.16 Million

Laboratorio Reig Jofre S.A - Advanced Valuation Insights

This section examines the relationship between Laboratorio Reig Jofre S.A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.03
Latest Market Cap to Assets Ratio 0.64
Asset Growth Rate (YoY) 4.3%
Total Assets €344.85 Million
Market Capitalization $221.39 Million USD

Valuation Analysis

Below Book Valuation: The market values Laboratorio Reig Jofre S.A's assets below their book value (0.64x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Laboratorio Reig Jofre S.A's assets grew by 4.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Laboratorio Reig Jofre S.A (2004–2024)

The table below shows the annual total assets of Laboratorio Reig Jofre S.A from 2004 to 2024.

Year Total Assets Change
2024-12-31 €344.85 Million
≈ $403.17 Million
+4.33%
2023-12-31 €330.55 Million
≈ $386.45 Million
+2.91%
2022-12-31 €321.19 Million
≈ $375.51 Million
-1.16%
2021-12-31 €324.98 Million
≈ $379.93 Million
+2.47%
2020-12-31 €317.15 Million
≈ $370.78 Million
+1.13%
2019-12-31 €313.62 Million
≈ $366.65 Million
+42.76%
2018-12-31 €219.68 Million
≈ $256.82 Million
+8.03%
2017-12-31 €203.34 Million
≈ $237.72 Million
-1.12%
2016-12-31 €205.63 Million
≈ $240.41 Million
+9.93%
2015-12-31 €187.05 Million
≈ $218.69 Million
+3.49%
2014-12-31 €180.74 Million
≈ $211.31 Million
+106.78%
2014-09-30 €87.41 Million
≈ $102.19 Million
+4.35%
2013-12-31 €83.77 Million
≈ $97.93 Million
-14.58%
2012-12-31 €98.06 Million
≈ $114.64 Million
-40.71%
2011-12-31 €165.38 Million
≈ $193.34 Million
-9.67%
2010-12-31 €183.09 Million
≈ $214.05 Million
-8.54%
2009-12-31 €200.18 Million
≈ $234.03 Million
-34.90%
2008-12-31 €307.50 Million
≈ $359.50 Million
-3.17%
2007-12-31 €317.55 Million
≈ $371.25 Million
+9.89%
2006-12-31 €288.98 Million
≈ $337.84 Million
+84.77%
2005-12-31 €156.40 Million
≈ $182.84 Million
+197.13%
2004-12-31 €52.64 Million
≈ $61.54 Million
--

About Laboratorio Reig Jofre S.A

MC:RJF Spain Drug Manufacturers - Specialty & Generic
Market Cap
$248.36 Million
€212.44 Million EUR
Market Cap Rank
#16262 Global
#105 in Spain
Share Price
€2.61
Change (1 day)
+1.95%
52-Week Range
€2.33 - €3.20
All Time High
€5.92
About

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables … Read more